FDA Authorizes New IV Drug for Treatment of Seriously Ill Flu Patients
2009 年10月27 日
Health Care Providers Can Request Peramivir Through CDC Electronic System
In response to a request from the U.S. Centers for Disease Control and Prevention, the U.S. Food and Drug Administration announced on October 23rd that it has issued an emergency use authorization (EUA) for the investigational antiviral drug peramivir intravenous (IV) in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital.
CDC has developed an electronic request system that lets healthcare providers request peramivir for patients who have been hospitalized due to 2009 H1N1 influenza. The Peramivir IV Electronic Request System can be found by clicking 這裡。
The FDA has reviewed the available scientific data and has concluded that the criteria for authorizing the emergency use of IV peramivir have been met.
There are no FDA-approved intravenously administered antivirals for the treatment of influenza. Peramivir is the only intravenously administered influenza treatment currently authorized for use under EUA for 2009 H1N1 infections.
Click 這裡 for more information
